SCHEMBL18974996

SCHEMBL18974996

CO[C@H]1C(=O)N(C)c2ccccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ MAPT P10636 1/20 0.41
▸ HDAC4 P56524 1/20 0.41
▸ HDAC7 Q8WUI4 1/20 0.41
▸ HDAC5 Q9UQL6 1/20 0.41
▸ GLRA3 O75311 1/20 0.38
▸ GLRA1 P23415 1/20 0.38
▸ GLRB P48167 1/20 0.38
▸ EGFR P00533 2/20 0.37
▸ ACHE P22303 3/20 0.37
▸ AADAT Q8N5Z0 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30067738 1.00 KDM4E (0.44) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL7815749 0.80 AADAT (0.36) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL28537633 0.80 MEN1 (0.45) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL17974970 0.75 MEN1 (0.49) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL26017423 0.75 BRD4 (0.49) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL29557464 0.75 BRD4 (0.49) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL769455 0.75 BRD4 (0.49) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL24664741 0.74 ALDH1A1 (0.65) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL9135785 0.74 HDAC4 (0.47) LMNAHDAC4HDAC7HDAC5EGFR
SCHEMBL5321137 0.73 AADAT (0.46) KDM4EALDH1A1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017099695-A1 N-[(AMINOSULFONYL)PHENYL]-2-(1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)-HYDRAZINECARBOTHIOAMIDE DERIVATIVES FOR TREATING CANCER AND IMMUNOLOGICAL DISORDERS ISTANBUL UNIVERSITESI REKTORLUGU (TR) 2017-06-15 — — WO disclosed
Send feedback